Table 4 Total metabolic active tumour volume repeatability for different tracer uptake intervals, reconstruction settings, and lesion delineation methods
Method | 60 min of uptake | 90 min of uptake | ||||
|---|---|---|---|---|---|---|
TRT (RC) | TRT% (RC%) | ICC | TRT (RC) | TRT% (RC%) | ICC | |
EARL | ||||||
SUV25 | 29.7 (211) | 5.9 (51) | 0.93 | 9.4 (35) | 3.7 (15) | 1.00 |
SUV40 | 2.5 (44) | 1.0 (31) | 0.99 | 3.5 (17) | 7.9 (32) | 1.00 |
41MAX | 4.5 (35) | 7.8 (45) | 0.99 | 6.5 (30) | 3.0 (14) | 1.00 |
A50P | 0.4 (38) | 5.9 (49) | 0.92 | 16.2 (77) | 10.5 (37) | 0.83 |
MV2 | 9.4 (48) | 9.3 (44) | 0.99 | 5.4 (24) | 3.5 (15) | 1.00 |
MV3 | − 4.2 (36) | 1.2 (39) | 0.94 | 15.7 (78) | 9.1 (38) | 0.83 |
RD | − 5.7 (82) | − 9.8 (61) | 0.96 | |||
PSF | ||||||
SUV25 | 46.0 (171) | 14.9 (44) | 0.95 | 139.5 (738) | 14.4 (63) | 0.65 |
SUV40 | 3.4 (23) | 1.8 (29) | 1.00 | 3.8 (19) | 5.6 (22) | 1.00 |
41MAX | 3.2 (17) | 6.9 (35) | 1.00 | 17.4 (92) | 6.2 (30) | 0.92 |
A50P | 2.1 (15) | 0.2 (19) | 0.99 | 5.7 (19) | 8.2 (21) | 0.98 |
MV2 | 5.4 (25) | 3.0 (35) | 1.00 | 14.5 (75) | 5.6 (22) | 0.98 |
MV3 | 2.8 (14) | 3.1 (18) | 1.00 | 3.7 (20) | 3.9 (21) | 0.98 |